Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 11/20 | 0.44 |
| ▸ | DPP8 | Q6V1X1 | 7/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 7/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | DPP7 | Q9UHL4 | 6/20 | 0.40 |
| ▸ | IARS1 | P41252 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30552158 | 1.00 | DPP4 (0.44) | DPP4DPP8DPP9ALOX15ALDH1A1 | |
| SCHEMBL20902879 | 1.00 | DPP4 (0.44) | DPP4DPP8DPP9ALOX15ALDH1A1 | |
| SCHEMBL28599405 | 1.00 | DPP4 (0.44) | DPP4DPP8DPP9ALOX15ALDH1A1 | |
| SCHEMBL29087496 | 1.00 | DPP4 (0.44) | DPP4DPP8DPP9ALOX15ALDH1A1 | |
| SCHEMBL1685517 | 1.00 | DPP4 (0.44) | DPP4DPP8DPP9ALOX15ALDH1A1 | |
| SCHEMBL13482942 | 1.00 | DPP4 (0.44) | DPP4DPP8DPP9ALOX15ALDH1A1 | |
| SCHEMBL199058 | 1.00 | DPP4 (0.44) | DPP4DPP8DPP9ALOX15ALDH1A1 | |
| Hydrochloric Acid SCHEMBL2777940 | 0.98 | DPP4 (0.43) | DPP4DPP8DPP9ALOX15ALDH1A1 | |
| Hydrochloric Acid SCHEMBL29087500 | 0.98 | DPP4 (0.43) | DPP4DPP8DPP9ALOX15ALDH1A1 | |
| Hydrochloric Acid SCHEMBL4277313 | 0.98 | DPP4 (0.43) | DPP4DPP8DPP9ALOX15ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 244 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137837-A1 | BONE GRAFT MATERIAL AND BONE FORMATION METHOD USING SAME | Y BON BIO INC (KR) | 2026-05-21 | — | — | US | claimed |
| CN-122056386-A | Moisture absorption resistant slow release microcapsule powder and preparation method and application thereof | 大连医诺生物股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122030612-A | Shear-resistant slow-release microcapsule powder and preparation method and application thereof | 大连医诺生物股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| EP-4673426-A1 | FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE | Locus Solutions IPCO, LLC (US) | 2026-01-07 | — | — | EP | claimed |
| EP-4603113-A1 | BONE GRAFT MATERIAL AND BONE FORMATION METHOD USING SAME | Y-Bon Bio Inc. (KR) | 2025-08-20 | — | — | EP | claimed |
| US-12168719-B2 | Composition of thermosensitive hydrogels having altered reversible sol-gel transition property, and use thereof | Nexgel Biotech Co. Ltd (KR) | 2024-12-17 | — | — | US | claimed |
| US-20240301322-A1 | FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE | LOCUS SOLUTIONS IPCO LLC (US) | 2024-09-12 | — | — | US | claimed |
| WO-2024182125-A1 | FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE | LOCUS SOLUTIONS IPCO, LLC (US) | 2024-09-06 | — | — | WO | claimed |
| WO-2024175614-A1 | STABLE LIQUID FORMULATIONS COMPRISING (6S)-5-METHYLTETRAHYDROFOLIC ACID OR SALTS THEREOF | MERCK PATENT GMBH (DE) | 2024-08-29 | — | — | WO | claimed |
| WO-2024080737-A1 | BONE GRAFT MATERIAL AND BONE FORMATION METHOD USING SAME | 연세대학교 산학협력단 | 2024-04-18 | — | — | WO | claimed |
| EP-3817812-A1 | CRYSTALLINE SALT OF 5-METHYL-(6S)-TETRAHYDROFOLIC ACID AND L-ISOLEUCINE ETHYL ESTER | Merck Patent GmbH (DE) | 2021-05-12 | — | — | EP | claimed |
| CN-112351818-A | Crystalline salts of 5-methyl- (6S) -tetrahydrofolic acid and ethyl L-isoleucine | 默克专利股份有限公司 | 2021-02-09 | — | — | CN | claimed |
| US-10603404-B2 | Phosphazene-based polymer for tissue adhesion, a method for preparing the same, and use thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2020-03-31 | — | — | US | claimed |
| WO-2020007836-A1 | CRYSTALLINE SALT OF 5-METHYL-(6S)-TETRAHYDROFOLIC ACID AND L-ISOLEUCINE ETHYL ESTER | MERCK PATENT GMBH (DE) | 2020-01-09 | — | — | WO | claimed |
| CN-108129404-A | The synthetic method of chiral piperazine ketone derivatives | 凯瑞斯德生化(苏州)有限公司 | 2018-06-08 | — | — | CN | claimed |
| US-20180133362-A1 | Phosphazene-based polymer for tissue adhesion, a method for preparing the same, and use thereof | NEXGEL BIOTECH CO., LTD (KR) | 2018-05-17 | — | — | US | claimed |
| EP-2155806-A1 | PHOSPHAZENE HYDROGELS WITH CHEMICAL CORSS -LINK, PREPARATION METHOD THEREOF AND USE THEREOF | Korea Institute of Science and Technology (KR) | 2010-02-24 | — | — | EP | claimed |
| WO-2008153278-A1 | PHOSPHAZENE HYDROGELS WITH CHEMICAL CORSS -LINK, PREPARATION METHOD THEREOF AND USE THEREOF | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2008-12-18 | — | — | WO | claimed |
| US-4940662-A | Low-molecular weight peptide mixture and method of producing same | TERUMO KABUSHIKI KAISHA (JP) | 1990-07-10 | — | — | US | claimed |
| CN-1032538-A | THERAPEUTIC ACYCLIC NUCLEOSIDES | WELLCOME FOUND (GB) | 1989-04-26 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260137837-A1 | BONE GRAFT MATERIAL AND BONE FORMATION METHOD USING SAME | BMP2, BMP1, BMP6 | DPP4 2449/4885DPP8 2751/4885DPP9 2580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.